UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alternative activation of macrophages: an immunologic functional perspective

Annual review of immunology, 2009-01, Vol.27 (1), p.451-483

2009

Volltextzugriff (PDF)

Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences

Blood, 2013-02, Vol.121 (9), p.e57-e69

2013

Volltextzugriff (PDF)

Genetic basis of cell–cell fusion mechanisms

Trends in genetics, 2013-07, Vol.29 (7), p.427-437

2013

Volltextzugriff (PDF)

Macrophage fusion induced by IL‐4 alternative activation is a multistage process involving multiple target molecules

European Journal of Immunology, 2007-01, Vol.37 (1), p.33-42

2007

Volltextzugriff (PDF)

scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion

Journal of cell science, 2009-02, Vol.122 (4), p.453-459

2009

Volltextzugriff (PDF)

Multinucleated Giant Cells Are Specialized for Complement-Mediated Phagocytosis and Large Target Destruction

Cell reports (Cambridge), 2015-12, Vol.13 (9), p.1937-1948

2015

Volltextzugriff (PDF)

Clearance of Fetuin-A–Containing Calciprotein Particles Is Mediated by Scavenger Receptor-A

Circulation research, 2012-08, Vol.111 (5), p.575-584

2012

Volltextzugriff (PDF)

Hepatic Localization of Macrophage Phenotypes during Fibrogenesis and Resolution of Fibrosis in Mice and Humans

Frontiers in immunology, 2014-09, Vol.5, p.430

2014

Volltextzugriff (PDF)

Molecular mediators of macrophage fusion

Trends in cell biology, 2009-10, Vol.19 (10), p.514-522

2009

Volltextzugriff (PDF)

Development of a c-MET x CD137 bispecific antibody for targeted immune agonism in cancer immunotherapy

Cancer treatment and research communications, 2024, Vol.39, p.100805, Article 100805

2024

Volltextzugriff (PDF)

Inflammation: Cell Recruitment versus Local Proliferation

Current biology, 2011-07, Vol.21 (14), p.R548-R550

Helming, Laura

2011

Volltextzugriff (PDF)

Defective immuno- and thymoproteasome assembly causes severe immunodeficiency

Scientific reports, 2018-04, Vol.8 (1), p.5975-18, Article 5975

2018

Volltextzugriff (PDF)

The molecular basis of macrophage fusion

Immunobiology (1979), 2007-01, Vol.212 (9), p.785-793

2007

Volltextzugriff (PDF)

The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal

Journal of biology (London, England), 2004, Vol.3 (4), p.15-15, Article 15

2004

Volltextzugriff (PDF)

Abstract 5305: M9657, a tumor-targeted anti-CD137 agonist, induced significant antitumor immunity in combination with anti-PD-1 antibody

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5305-5305

2024

Volltextzugriff (PDF)

High-Throughput Screening and Proteomic Characterization of Compounds Targeting Myeloid-Derived Suppressor Cells

Molecular & cellular proteomics, 2023-09, Vol.22 (9), p.100632-100632, Article 100632

2023

Volltextzugriff (PDF)

Genetic screen in myeloid cells identifies TNF-α autocrine secretion as a factor increasing MDSC suppressive activity via Nos2 up-regulation

Scientific reports, 2018-09, Vol.8 (1), p.13399-12, Article 13399

2018

Volltextzugriff (PDF)

1α,25-dihydroxyvitamin D3 is a potent suppressor of interferon γ–mediated macrophage activation

Blood, 2005-12, Vol.106 (13), p.4351-4358

2005

Volltextzugriff (PDF)

Abstract 4126: Anti-tumor immunity of M9657, a conditional CD137 immune agonist, is correlated with mesothelin expression on tumor cells

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4126-4126

2023

Volltextzugriff (PDF)

M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation

Cancer immunology research, 2024-02, p.OF1-OF19

2024

Volltextzugriff (PDF)

Identification of inhibitors of myeloid-derived suppressor cells activity through phenotypic chemical Screening

The Journal of immunology (1950), 2017-05, Vol.198 (1_Supplement), p.205-205.9

2017

Volltextzugriff (PDF)

The activity of myeloid cell-specific VHH immunotoxins is target-, epitope-, subset- and organ dependent

Scientific reports, 2017-12, Vol.7 (1), p.17916-10, Article 17916

2017

Volltextzugriff (PDF)

Essential role of DAP12 signaling in macrophage programming into a fusion-competent state

Science signaling, 2008-10, Vol.1 (43), p.ra11

2008

Volltextzugriff (PDF)

Abstract A099: Using high-throughput phenotypic screening to identify therapeutic targets for the inhibition of myeloid-derived suppressor cells

Cancer immunology research, 2019-02, Vol.7 (2_Supplement), p.A099-A099

2019

Volltextzugriff (PDF)

ID: 43: The IL-13 receptor-alpha 1 chain is essential for induction of the alternative macrophage activation pathway by IL-13 but not IL-4

Cytokine (Philadelphia, Pa.), 2015-11, Vol.76 (1), p.72-72

2015

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alternative activation of macrophages: an immunologic functional perspective

Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences

Genetic basis of cell–cell fusion mechanisms

Macrophage fusion induced by IL‐4 alternative activation is a multistage process involving multiple target molecules

scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion

Multinucleated Giant Cells Are Specialized for Complement-Mediated Phagocytosis and Large Target Destruction

Clearance of Fetuin-A–Containing Calciprotein Particles Is Mediated by Scavenger Receptor-A

Hepatic Localization of Macrophage Phenotypes during Fibrogenesis and Resolution of Fibrosis in Mice and Humans

Molecular mediators of macrophage fusion

Development of a c-MET x CD137 bispecific antibody for targeted immune agonism in cancer immunotherapy

Inflammation: Cell Recruitment versus Local Proliferation

Defective immuno- and thymoproteasome assembly causes severe immunodeficiency

The molecular basis of macrophage fusion

The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal

Abstract 5305: M9657, a tumor-targeted anti-CD137 agonist, induced significant antitumor immunity in combination with anti-PD-1 antibody

High-Throughput Screening and Proteomic Characterization of Compounds Targeting Myeloid-Derived Suppressor Cells

Genetic screen in myeloid cells identifies TNF-α autocrine secretion as a factor increasing MDSC suppressive activity via Nos2 up-regulation

1α,25-dihydroxyvitamin D3 is a potent suppressor of interferon γ–mediated macrophage activation

Abstract 4126: Anti-tumor immunity of M9657, a conditional CD137 immune agonist, is correlated with mesothelin expression on tumor cells

M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation

Identification of inhibitors of myeloid-derived suppressor cells activity through phenotypic chemical Screening

The activity of myeloid cell-specific VHH immunotoxins is target-, epitope-, subset- and organ dependent

Essential role of DAP12 signaling in macrophage programming into a fusion-competent state

Abstract A099: Using high-throughput phenotypic screening to identify therapeutic targets for the inhibition of myeloid-derived suppressor cells

ID: 43: The IL-13 receptor-alpha 1 chain is essential for induction of the alternative macrophage activation pathway by IL-13 but not IL-4

Suchergebnisse filtern